Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon‐Like Peptide‐1 Receptor Agonist and Sodium‐Glucose Cotransporter‐2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta‐Analysis

BACKGROUND: Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) have shown their beneficial effects on cardiovascular outcomes and multiple cardiovascular risk factors, including hypertension. However, the mechanism of blood pressure (BP)–lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Mengdie, Cai, Xiaoling, Yang, Wenjia, Zhang, Simin, Nie, Lin, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Systematic Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428598/
https://www.ncbi.nlm.nih.gov/pubmed/32223390
http://dx.doi.org/10.1161/JAHA.119.015323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428598/
https://www.ncbi.nlm.nih.gov/pubmed/32223390
http://dx.doi.org/10.1161/JAHA.119.015323

Ejemplares similares